Fatty liver disease (MASLD/MASH) trials in Switzerland

In Switzerland 12 Also abroad 367

12 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
Where
Bern, Olten, Sankt Gallen
Age
18 years to 80 years
People
1,650 worldwide
Run by
Akero Therapeutics, Inc
See details and how to joinNCT06215716
Phase 3Taking people
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Where
Arzo, Bern, Geneva, Zurich
Age
18 years and over
People
1,800 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT06632444 · EU 2024-513739-25-00
Phase 3Taking people
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Where
Arzo, Geneva, Zurich
Age
18 years and over
People
1,590 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT06632457 · EU 2024-513741-36-00
Phase 3Taking people
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Where
Bern, Lugano, Olten, Sankt Gallen, Zurich
Age
18 years to 80 years
People
2,150 worldwide
Run by
Akero Therapeutics, Inc
See details and how to joinNCT06528314
Phase 3Taking people
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Where
Basel, Olten
Age
18 years and over
People
4,500 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07165028 · EU 2025-522674-36-00
No phaseNot yet taking people in Switzerland
GLP-1 RA on Alcohol Consumption, Metabolism and Liver Parameters in Patients With Obesity and Fatty Liver Disease
Where
Bern
Age
18 years to 80 years
People
64
Run by
Insel Gruppe AG, University Hospital Bern
See details and how to joinNCT06546384
Phase 4Taking people
Fibrosis Lessens After Metabolic Surgery
Where
Basel, Geneva
Age
18 years to 75 years
People
120 worldwide
Run by
The Cleveland Clinic
See details and how to joinNCT06374875
No phaseTaking people
Prospective Cohort and Biobank of Patients With Nonalcoholic Fatty Liver Disease
Where
Lugano
Age
18 years and over
People
300
Run by
Fondazione Epatocentro Ticino
See details and how to joinNCT07051863
No phaseTaking people
The Development of MASLD Among Survivors of Breast or Colorectal Cancer
Where
Bern
Age
18 years and over
People
200
Run by
University of Bern
See details and how to joinNCT07280143
No phaseTaking people
Identification of Hepatic Fibrosis Using 4D-MRI
Where
Basel, Liestal
Age
18 years and over
People
200
Run by
University Hospital, Basel, Switzerland
See details and how to joinNCT05385237
No phaseTaking people
The European NAFLD Registry
Where
Bern
Age
18 years to 100 years
People
10,000 worldwide
Run by
Newcastle University
See details and how to joinNCT04442334
No phaseTaking people
Prospective Cohort Study in Patients With NAFLD
Where
Zurich
Age
18 years and over
People
150
Run by
University of Zurich
See details and how to joinNCT00575133